Patents by Inventor Christopher S. Jones
Christopher S. Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20140200605Abstract: Tissue expanders and their methods of use.Type: ApplicationFiled: March 14, 2014Publication date: July 17, 2014Inventors: Christopher S. JONES, Daniel JACOBS, F. Mark PAYNE, David S. MINTZ, Craig A. PURDY, Ryan S. HAN, Tadmor SHALON
-
Publication number: 20140112749Abstract: An industrial machine includes a frame supporting a boom having a first end and a second end opposite the first end, an arm movably coupled to the boom and including a first end and a second end, an attachment coupled to the first end of the arm, a conduit extending from the frame to a position adjacent the attachment, a first member coupled to the boom, and a second member spaced apart from the first member. The first member supports a portion of the conduit as the arm moves relative to the boom. The second member supports a portion of the conduit as the arm moves relative to the boom. The second member is movable relative to the first member.Type: ApplicationFiled: October 18, 2013Publication date: April 24, 2014Inventors: Robert Doll, Christopher S. Jones, Jesse Knoble, Matthew Loew, Douglas Maki, Bernard Pusheck
-
Publication number: 20140112748Abstract: An industrial machine includes a frame supporting a fluid source and a boom, an arm, an attachment coupled to the arm, a cylinder, and a rod. The arm is movably coupled to the boom for translational and rotational movement relative to the boom. The cylinder includes a first end and a second end, and the cylinder defines an internal bore in fluid communication with the fluid source. The rod is coupled to the arm and is slidably received within the cylinder. The rod includes a port and a passage for providing fluid to the attachment. The port provides fluid communication between the internal bore and the passage. The port is positioned within the internal bore throughout the entire range of movement of the rod relative to the cylinder.Type: ApplicationFiled: October 18, 2013Publication date: April 24, 2014Applicant: Harnischfeger Technologies, Inc.Inventors: Robert Doll, Christopher S. Jones, Jesse Knoble, Matthew Loew, Russell Luzinski, Daniel Schlegel
-
Publication number: 20140099179Abstract: An industrial machine includes a frame, an elongated member, an attachment, a plurality of fluid lines, and a cartridge. The frame includes a boom and a fluid source. The elongated member is movably coupled to the boom and includes a first end and a second end. The attachment is pivotably coupled to the first end of the elongated member. The plurality of fluid lines is coupled to the second end of the elongated member and is in fluid communication with the fluid source. The cartridge is removably coupled to the elongated member. The cartridge includes a housing and a plurality of conduits supported within the housing. The conduits are in fluid communication with the plurality of lines.Type: ApplicationFiled: October 3, 2013Publication date: April 10, 2014Applicant: Harnischfeger Technologies, Inc.Inventor: Christopher S. Jones
-
Patent number: 8679110Abstract: A catheter includes a plurality of primary leads to deliver energy for ligating a hollow anatomical structure. Each of the primary leads includes an electrode located at the working end of the catheter. Separation is maintained between the primary leads such that each primary lead can individually receive power of selected polarity. The primary leads are constructed to expand outwardly to place the electrodes into apposition with an anatomical structure. High frequency energy can be applied from the leads to create a heating effect in the surrounding tissue of the anatomical structure. The diameter of the hollow anatomical structure is reduced by the heating effect, and the electrodes of the primary leads are moved closer to one another. Where the hollow anatomical structure is a vein, energy is applied until the diameter of the vein is reduced to the point where the vein is occluded. In one embodiment, a secondary lead is surrounded by the primary leads, and extends beyond the primary leads.Type: GrantFiled: July 28, 2008Date of Patent: March 25, 2014Assignee: Covidien LPInventors: Arthur W. Zikorus, Mark P. Parker, Christopher S. Jones, Douglas M. Petty, Brian E. Farley, Joseph M. Tartaglia
-
Patent number: 8632498Abstract: Devices and methods for tissue transfer are described where a cannula may be inserted into the breast of a subject at one of several points of entry. Insertion of the cannula into the breast may be accomplished by using a guidance system to distinguish between tissue types. Once desirably positioned, the cannula may be withdrawn from the breast while automatically (or manually) injecting the fat in multiple deposits of adipose tissue or fat such that the deposited fat remains within the tract formed by the withdrawn cannula. Multiple tracts of the deposited fat may be injected within the breast until the breast has been desirably remodeled and/or augmented.Type: GrantFiled: October 31, 2012Date of Patent: January 21, 2014Assignee: TauTona Group Research and Development Company, L.L.C.Inventors: Joseph Rimsa, Brian J. Domecus, Christopher S. Jones, Paul James Lingane
-
Patent number: 8617198Abstract: Tissue expanders and their methods of use.Type: GrantFiled: December 7, 2011Date of Patent: December 31, 2013Assignees: AirXpanders, Inc., Shalon Ventures, Inc.Inventors: Christopher S. Jones, Daniel Jacobs, F. Mark Payne, David S. Mintz, Craig A. Purdy, Ryan S. Han, Tadmor Shalon
-
Patent number: 8597248Abstract: Devices and methods for tissue transfer are described where a cannula may be inserted into the breast of a subject at one of several points of entry. Insertion of the cannula into the breast may be accomplished by using a guidance system to distinguish between tissue types. Once desirably positioned, the cannula may be withdrawn from the breast while automatically (or manually) injecting the fat in multiple deposits of adipose tissue or fat such that the deposited fat remains within the tract formed by the withdrawn cannula. Multiple tracts of the deposited fat may be injected within the breast until the breast has been desirably remodeled and/or augmented.Type: GrantFiled: October 31, 2012Date of Patent: December 3, 2013Assignee: TauTona Group Research and Development Company, L.L.P.Inventors: Joseph Rimsa, Brian J. Domecus, Christopher S. Jones, Paul James Lingane
-
Publication number: 20130150825Abstract: Devices and methods for tissue transfer are described where a cannula may be inserted into the breast of a subject at one of several points of entry. Insertion of the cannula into the breast may be accomplished by using a guidance system to distinguish between tissue types. Once desirably positioned, the cannula may be withdrawn from the breast while automatically (or manually) injecting the fat in multiple deposits of adipose tissue or fat such that the deposited fat remains within the tract formed by the withdrawn cannula. Multiple tracts of the deposited fat may be injected within the breast until the breast has been desirably remodeled and/or augmented.Type: ApplicationFiled: October 31, 2012Publication date: June 13, 2013Inventors: Joseph RIMSA, Brian J. DOMECUS, Christopher S. JONES, Paul James LINGANE
-
Publication number: 20130131635Abstract: Devices and methods for tissue transfer are described where a cannula may be inserted into the breast of a subject at one of several points of entry. Insertion of the cannula into the breast may be accomplished by using a guidance system to distinguish between tissue types. Once desirably positioned, the cannula may be withdrawn from the breast while automatically (or manually) injecting the fat in multiple deposits of adipose tissue or fat such that the deposited fat remains within the tract formed by the withdrawn cannula. Multiple tracts of the deposited fat may be injected within the breast until the breast has been desirably remodeled and/or augmented.Type: ApplicationFiled: January 16, 2013Publication date: May 23, 2013Inventors: Joseph RIMSA, Brian J. DOMECUS, Christopher S. JONES, Paul James LINGANE
-
Publication number: 20130116782Abstract: Apparatus and methods for nipple and breast formation are described where devices precondition or expand a target nipple tissue to reduce the pressure exerted by the skin on an eventual implant. Generally, the apparatus comprises a mold having a contact surface which is curved in conformance with a breast upon which the mold is positionable, the contact surface having an adhesive for securement upon the breast, and the mold defining a cavity along the contact surface which conforms to a size of a nipple to be formed upon the breast and where the cavity further comprises the adhesive for securement to the nipple. A breast enlargement device comprises a cup larger than the target breast and further defines an inner surface which adheres to the breast when contacted.Type: ApplicationFiled: September 7, 2012Publication date: May 9, 2013Applicant: Tau Tona Group Research and Development Company, L.L.C.Inventors: Kenneth N. HORNE, Sergio SALINAS, Geoffrey C. GURTNER, Michael H. ROSENTHAL, Christopher S. JONES, Joseph RIMSA
-
Patent number: 8431597Abstract: The present invention relates to a compound of the Formula I or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3A, R3B, R4, R5, X, m, and n are as defined herein. Such novel benzamidazole derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to a method of using such compounds in the treatment of abnormal cell growth in mammals, especially humans, and to pharmaceutical compositions containing such compounds.Type: GrantFiled: February 24, 2012Date of Patent: April 30, 2013Assignee: Pfizer Inc.Inventors: Michael J. Munchhof, Lawrence A. Reiter, Susan D. La Greca, Christopher S. Jones, Qifang Li
-
Patent number: 8394118Abstract: Tissue expanders and their methods of use.Type: GrantFiled: December 7, 2011Date of Patent: March 12, 2013Assignees: AirXpanders, Inc., Shalon Ventures, Inc.Inventors: Christopher S. Jones, Daniel Jacobs, F. Mark Payne, David S. Mintz, Craig A. Purdy, Ryan S. Han, Tadmor Shalon
-
Patent number: 8267931Abstract: A catheter includes a plurality of expandable primary leads to deliver energy to a fallopian tube, a vein such as a hemorrhoid or an esophageal varix, or another hollow anatomical structure requiring ligation or occlusion. Each of the primary leads includes an electrode located at the working end of the catheter. Separation is maintained between the primary leads such that the leads can receive power of selected polarity. The primary leads are constructed to expand outwardly to place the electrodes into apposition with a hollow anatomical structure. High frequency energy can be applied from the leads to create a heating effect in the surrounding tissue of the anatomical structure. The diameter of the hollow anatomical structure is reduced by the heating effect, and the electrodes of the primary leads are moved closer to one another.Type: GrantFiled: October 24, 2008Date of Patent: September 18, 2012Assignee: Tyco Healthcare Group LPInventors: Brian E. Farley, Christopher S. Jones, Mark P. Parker, Joseph M. Tartaglia, Arthur W. Zikorus
-
Patent number: 8260653Abstract: A change risk assessment system is disclosed. A question-and-answer approach is used to generate a risk assessment that can be broken down by various business categories. Scoring in example embodiments generates a risk level for each identified that takes into account high severity and low detectability characteristics of specific risks associated with a change or new project. The highest average risk priority number (RPN) from any category can be used to facilitate cross-project comparison of risk and reward balance. A risk level can be calculated for both an inherent risk, and a residual risk. The residual risk is calculated taking a mitigation plan into account. A color indication can be displayed for each identified risk, where the color indication is indicative of the risk level. The scoring for an identified risk can also be made to programmatically prompt escalation of the identified issue.Type: GrantFiled: July 23, 2009Date of Patent: September 4, 2012Assignee: Bank of America CorporationInventors: Susan Osterfelt, Steven Lappert, Christopher S. Jones
-
Publication number: 20120157495Abstract: The present invention relates to a compound of the Formula I or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3A, R3B, R4, R5, X, m, and n are as defined herein. Such novel benzamidazole derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to a method of using such compounds in the treatment of abnormal cell growth in mammals, especially humans, and to pharmaceutical compositions containing such compounds.Type: ApplicationFiled: February 24, 2012Publication date: June 21, 2012Inventors: Michael J. MUNCHHOF, Lawrence A. Reiter, Susan D. La Greca, Christopher S. Jones, Qifang Li
-
Publication number: 20120101575Abstract: Apparatus and methods for nipple and breast formation are described where devices precondition or expand a target nipple tissue to reduce the pressure exerted by the skin on an eventual implant. Generally, the apparatus comprises a mold having a contact surface which is curved in conformance with a breast upon which the mold is positionable, the contact surface having an adhesive for securement upon the breast, and the mold defining a cavity along the contact surface which conforms to a size of a nipple to be formed upon the breast and where the cavity further comprises the adhesive for securement to the nipple. A breast enlargement device comprises a cup larger than the target breast and further defines an inner surface which adheres to the breast when contacted.Type: ApplicationFiled: October 20, 2011Publication date: April 26, 2012Applicant: TauTona Group Research and Development Company, L.L.C.Inventors: Kenneth N. HORNE, Michael H. ROSENTHAL, Geoffrey C. GURTNER, Christopher S. Jones, Sergio Salinas, Joseph Rimsa
-
Patent number: 8148401Abstract: The present invention relates to a compound of the Formula I or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3A, R3B, R4, R5, X, m, and n are as defined herein. Such novel benzamidazole derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to a method of using such compounds in the treatment of abnormal cell growth in mammals, especially humans, and to pharmaceutical compositions containing such compounds.Type: GrantFiled: June 19, 2008Date of Patent: April 3, 2012Assignee: Pfizer Inc.Inventors: Michael J. Munchhof, Lawrence A. Reiter, Susan D. La Greca, Christopher S. Jones, Qifang Li
-
Publication number: 20120078284Abstract: Tissue expanders and their methods of use.Type: ApplicationFiled: December 7, 2011Publication date: March 29, 2012Inventors: Christopher S. JONES, Daniel JACOBS, F. Mark PAYNE, David S. MINTZ, Craig A. PURDY, Ryan S. HAN, Tadmor SHALON
-
Publication number: 20120078366Abstract: Tissue expanders and their methods of use.Type: ApplicationFiled: December 7, 2011Publication date: March 29, 2012Inventors: Christopher S. Jones, Daniel Jacobs, F. Mark Payne, David S. Mintz, Craig A. Purdy, Ryan S. Han, Tadmor Shalon